GLICLAGLAZE TRIO 40/0.3
Item requires a valid prescription
Manufactured By Steris Healthcare Pvt Ltd
Composition Gliclazide IP (40 mg), Metformin Hydrochloride IP (500 mg), Voglibose IP (0.3 mg)
Rs 134.89
MRP Rs 192.70
(30% OFF)
Includes all taxes
Package SIZE
( For 15 tablets )
100% Authentic
Products
Free
Shipping*
Products
Return Policy
Description:
GLICLAGLAZE TRIO 40/0.3 is a triple fixed-dose combination medicine used in the management of Type 2 Diabetes Mellitus, specifically designed for patients whose blood sugar is not adequately controlled on a single anti-diabetic medicine or a two-drug combination. It brings together three well-established anti-diabetic agents, each targeting a different aspect of blood sugar regulation:
Gliclazide belongs to the sulfonylurea class and works by stimulating the pancreas to release more insulin, helping the body use available glucose more effectively.
Metformin Hydrochloride, a biguanide, works primarily by reducing the amount of glucose produced by the liver and improving the body's sensitivity to insulin at the cellular level, making existing insulin work more efficiently.
Voglibose, an alpha-glucosidase inhibitor, works in the intestine by slowing the breakdown and absorption of carbohydrates from food, which helps blunt the sharp rise in blood sugar that typically occurs after meals (post-prandial hyperglycemia).
By combining three complementary mechanisms into one tablet, GLICLAGLAZE TRIO 40/0.3 addresses blood sugar control from multiple angles at once — improving insulin availability, insulin sensitivity, and carbohydrate absorption — which can offer more comprehensive glycemic control than any single mechanism alone, particularly for patients with more advanced or harder-to-control Type 2 diabetes.
Product Information
| Attribute | Details |
|---|---|
| Brand Name | GLICLAGLAZE TRIO 40/0.3 |
| Composition | Gliclazide IP 40 mg + Metformin Hydrochloride IP 500 mg + Voglibose IP 0.3 mg |
| Therapeutic Class | Anti-diabetic — Sulfonylurea + Biguanide + Alpha-Glucosidase Inhibitor (Triple Combination) |
| Manufacturer/Marketer | Steris Healthcare Pvt. Ltd. |
| Product Form | Tablet |
| Pack Size | 15 Tablets |
| Prescription Status | Schedule H — Prescription drug only |
| Price (MRP) | ₹[Placeholder — insert price] |
| SKU / Batch Ref. | [Placeholder — insert SKU] |
| Storage | Store below 25°C, in a cool, dry place, protected from light and moisture |
Why GLICLAGLAZE TRIO 40/0.3 Is Important
Type 2 diabetes is a progressive condition, and for many patients, a single medicine eventually becomes insufficient to keep blood sugar within target range as the disease advances. Poorly controlled diabetes over time significantly raises the risk of serious complications — including damage to the eyes (retinopathy), kidneys (nephropathy), nerves (neuropathy), and cardiovascular system (heart attack and stroke).
GLICLAGLAZE TRIO 40/0.3 is clinically important because it:
- Offers comprehensive glycemic control by addressing three separate mechanisms of blood sugar regulation in a single tablet
- Helps control both fasting blood glucose (through Gliclazide and Metformin) and post-meal blood glucose spikes (through Voglibose)
- Simplifies treatment for patients who would otherwise need to take three separate tablets, improving convenience and adherence
- Supports long-term reduction in diabetes-related complications when blood sugar is kept within target range consistently
- Provides a valuable intensification option for patients whose diabetes has progressed beyond what one or two medicines can manage effectively
Because this is a triple-combination medicine involving three distinct drug classes, each with its own precautions and monitoring needs, it requires careful physician oversight to ensure it is the right fit for each patient's individual diabetes profile, kidney function, and overall health status.
Key Benefits
- Triple-mechanism action — addresses insulin release, insulin sensitivity, and carbohydrate absorption in one tablet
- Helps control both fasting and post-prandial (after-meal) blood glucose levels
- Reduces pill burden by combining three medicines into a single tablet, improving treatment adherence
- Supports better long-term glycemic control, reducing risk of diabetes-related complications over time
- Useful option for patients with inadequately controlled Type 2 diabetes on simpler regimens
- Backed by WHO-GMP certified manufacturing, ensuring consistent tablet quality and dosing accuracy
Precautions
- Should be used only under medical supervision, with regular monitoring of blood glucose, HbA1c, and kidney function
- Caution advised in patients with kidney impairment, as Metformin use requires dose adjustment or avoidance based on kidney function levels
- Risk of hypoglycemia (low blood sugar) exists, particularly due to the Gliclazide component — patients should be aware of symptoms (sweating, shakiness, confusion, dizziness) and how to manage them
- Should be used cautiously in patients with liver disease, heart failure, or conditions predisposing to lactic acidosis (a rare but serious risk associated with Metformin)
- Alcohol should be avoided or limited, as it can increase the risk of hypoglycemia and lactic acidosis
- Temporary discontinuation may be required before procedures involving contrast dye (imaging scans) or major surgery — inform all treating doctors that this medicine is being taken
- Not recommended during pregnancy or breastfeeding unless specifically advised by a physician, as alternative treatments are typically preferred
- Elderly patients may be more sensitive to hypoglycemia and should be monitored closely
- Inform the doctor of all other medications, as several drug classes can interact with components of this combination
Side Effects
- Gastrointestinal discomfort — nausea, bloating, flatulence, or diarrhea (particularly with the Metformin and Voglibose components, often improving over time)
- Hypoglycemia (low blood sugar) — more likely if meals are skipped or delayed
- Metallic taste in the mouth
- Loss of appetite
- Headache
- Dizziness
- Rarely: lactic acidosis (a serious condition requiring emergency care — symptoms include severe muscle pain, difficulty breathing, unusual tiredness, and stomach discomfort)
- Rarely: allergic skin reactions
Frequently Asked Questions
1. Where can I buy Glimepiride Voglibose and Metformin Hydrochloride Tablets online?
You can buy Glimepiride Voglibose and Metformin Hydrochloride Tablets through licensed online pharmacies or authorized pharmaceutical suppliers in India. Verify the manufacturer, strength, batch number, expiry date, and packaging before purchasing.
2. What is the price of Glimepiride Voglibose and Metformin Hydrochloride Tablets?
The price may vary depending on the brand, strength, pack size, manufacturer, seller, taxes, and delivery charges. Check the current price with a licensed pharmacy or authorized supplier.
3. Can I order Glimepiride Voglibose and Metformin Hydrochloride Tablets online?
Yes, these tablets can be ordered online where legally available. They are generally prescription medicines, so a valid prescription may be required. Purchase only through a licensed pharmacy or authorized supplier.
4. Is Glimepiride Voglibose and Metformin Hydrochloride Tablets available from Steris Healthcare?
Availability depends on Steris Healthcare's current product range and stock status. Contact Steris Healthcare or an authorized distributor to confirm the available strengths, pack size, price, and ordering details.
5. What is Glimepiride Voglibose and Metformin Hydrochloride Tablets used for?
This combination is used to help control blood glucose levels in people with type 2 diabetes mellitus, along with an appropriate diet and exercise plan. The three medicines work through different mechanisms to improve blood sugar control.
6. What is the composition of Glimepiride Voglibose and Metformin Hydrochloride Tablets?
These tablets contain three active ingredients: Glimepiride, Voglibose, and Metformin Hydrochloride. The exact strength of each ingredient depends on the specific product formulation.
7. Is a prescription required?
Yes, this combination is generally a prescription medicine and should be used under medical supervision. Your healthcare professional will determine the appropriate strength and dosage based on your blood glucose levels and treatment needs.
8. How should Glimepiride Voglibose and Metformin Hydrochloride Tablets be taken?
Take the tablets exactly as prescribed by your doctor. They are commonly taken with or around meals, depending on the specific formulation and prescription. Swallow the tablet with water and do not change the dose or stop treatment without medical advice.
9. What should I know before buying Glimepiride Voglibose and Metformin Hydrochloride Tablets?
Before buying, verify the exact strengths, formulation, manufacturer, batch number, expiry date, packaging, and storage instructions. Inform your doctor about kidney or liver problems, digestive disorders, pregnancy or breastfeeding, and all medicines or supplements you take. Glimepiride may cause low blood sugar in some patients.
10. How can I order Glimepiride Voglibose and Metformin Hydrochloride Tablets online?
To order these tablets online, choose a licensed pharmacy or authorized supplier, select the prescribed strength and pack size, provide a valid prescription if required, verify the product and expiry details, and complete the purchase.